Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 6 studies | 37% ± 20% | |
neuron | 3 studies | 29% ± 9% | |
GABAergic neuron | 3 studies | 37% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 42% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 12693.88 | 2582 / 2642 | 98% | 29.08 | 693 / 705 |
lung | 89% | 1208.98 | 512 / 578 | 59% | 3.32 | 684 / 1155 |
uterus | 91% | 1357.13 | 155 / 170 | 56% | 3.59 | 256 / 459 |
intestine | 92% | 1303.64 | 884 / 966 | 45% | 2.57 | 238 / 527 |
prostate | 69% | 772.22 | 168 / 245 | 56% | 1.99 | 281 / 502 |
stomach | 77% | 867.04 | 278 / 359 | 35% | 1.80 | 100 / 286 |
esophagus | 57% | 737.23 | 823 / 1445 | 54% | 3.08 | 98 / 183 |
blood vessel | 97% | 3007.75 | 1295 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 20% | 306.79 | 52 / 258 | 76% | 42.10 | 175 / 230 |
bladder | 57% | 750.19 | 12 / 21 | 36% | 1.84 | 183 / 504 |
breast | 31% | 281.60 | 143 / 459 | 57% | 3.04 | 634 / 1118 |
ovary | 50% | 434.21 | 90 / 180 | 35% | 1.48 | 151 / 430 |
lymph node | 0% | 0 | 0 / 0 | 83% | 7.72 | 24 / 29 |
tonsil | 0% | 0 | 0 / 0 | 82% | 5.61 | 37 / 45 |
skin | 32% | 269.89 | 575 / 1809 | 47% | 2.46 | 223 / 472 |
thymus | 13% | 96.99 | 83 / 653 | 54% | 2.20 | 326 / 605 |
eye | 0% | 0 | 0 / 0 | 64% | 3.16 | 51 / 80 |
kidney | 24% | 190.62 | 21 / 89 | 33% | 1.32 | 301 / 901 |
pancreas | 1% | 6.66 | 2 / 328 | 35% | 1.26 | 63 / 178 |
spleen | 23% | 163.79 | 56 / 241 | 0% | 0 | 0 / 0 |
heart | 16% | 153.81 | 137 / 861 | 0% | 0 | 0 / 0 |
adipose | 12% | 107.49 | 142 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 3.22 | 1 / 226 | 10% | 0.37 | 42 / 406 |
peripheral blood | 3% | 29.81 | 31 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.72 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0017156 | Biological process | calcium-ion regulated exocytosis |
GO_0050806 | Biological process | positive regulation of synaptic transmission |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0048791 | Biological process | calcium ion-regulated exocytosis of neurotransmitter |
GO_0042391 | Biological process | regulation of membrane potential |
GO_2000300 | Biological process | regulation of synaptic vesicle exocytosis |
GO_0048786 | Cellular component | presynaptic active zone |
GO_0048788 | Cellular component | cytoskeleton of presynaptic active zone |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
Gene name | RIMS3 |
Protein name | Alternative protein RIMS3 Regulating synaptic membrane exocytosis 3 isoform C Regulating synaptic membrane exocytosis protein 3 (Nim3) (RIM3 gamma) (Rab-3-interacting molecule 3) (RIM 3) |
Synonyms | KIAA0237 |
Description | FUNCTION: Regulates synaptic membrane exocytosis. . |
Accessions | Q9UJD0 L8EAQ2 ENST00000372683.1 [Q9UJD0-1] X5D2V8 ENST00000372684.8 [Q9UJD0-1] |